Alerts will be sent to your verified email
Verify Email
SUVEN
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Suven Life Sciences offers a wide range of Drug Discovery and Development Support Services to global Pharma and Biotech companies. Their services span across various scientific areas including chemistry, pharmacology, toxicology, and formulations.
Suven Life Sciences major competitors are Hikal, Piramal Pharma, Cohance Lifesciences, Sun Pharma Adv. Res, Dishman Carbogen Amc, Zenotech Laboratorie, Vivo Bio Tech.
Market Cap of Suven Life Sciences is ₹4,949 Crs.
While the median market cap of its peers are ₹4,437 Crs.
Suven Life Sciences seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May | Mar Jun Sep Dec | Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep | Mar Jun Sep Dec | Mar Sep Dec | Sep Dec | |||||||
| Investor Presentation | Jun | Mar Jun Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep | |||||||||
| Conference Call | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Sep Dec | |||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
